Medius Holdings Co., Ltd. (TYO:3154)
Japan · Delayed Price · Currency is JPY 845.00
-1.00 (-0.12%)
Aug 22, 2025, 3:30 PM JST
Medius Holdings Revenue
In the fiscal year ending June 30, 2025, Medius Holdings had annual revenue of 288.69B JPY with 11.12% growth. Medius Holdings had revenue of 69.18B in the quarter ending June 30, 2025, with 3.76% growth.
Revenue
288.69B
Revenue Growth
+11.12%
P/S Ratio
0.07
Revenue / Employee
114.70M
Employees
2,517
Market Cap
18.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 288.69B | 28.90B | 11.12% |
| Jun 30, 2024 | 259.79B | 20.74B | 8.67% |
| Jun 30, 2023 | 239.05B | 12.45B | 5.49% |
| Jun 30, 2022 | 226.61B | -20.18B | -8.18% |
| Jun 30, 2021 | 246.79B | 36.40B | 17.30% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |